Valerie Durkalski-Mauldin to Humans
This is a "connection" page, showing publications Valerie Durkalski-Mauldin has written about Humans.
Connection Strength
0.292
-
Time-trend impact on treatment estimation in two-arm clinical trials with a binary outcome and Bayesian response adaptive randomization. J Biopharm Stat. 2020; 30(1):69-88.
Score: 0.025
-
Considering prehospital stroke trials: did RIGHT-2 get it right? Lancet. 2019 03 09; 393(10175):963-965.
Score: 0.025
-
Impact of adaptation algorithm, timing, and stopping boundaries on the performance of Bayesian response adaptive randomization in confirmative trials with a binary endpoint. Contemp Clin Trials. 2017 11; 62:114-120.
Score: 0.023
-
The EPISOD study: long-term outcomes. Gastrointest Endosc. 2018 Jan; 87(1):205-210.
Score: 0.022
-
Adaptive designs: a true panacea for the common clinical trial? Ann Emerg Med. 2012 Oct; 60(4):449-50.
Score: 0.016
-
Challenges in the design and analysis of non-inferiority trials: a case study. Clin Trials. 2011 Oct; 8(5):601-8.
Score: 0.015
-
Measuring episodic abdominal pain and disability in suspected sphincter of Oddi dysfunction. World J Gastroenterol. 2010 Sep 21; 16(35):4416-21.
Score: 0.014
-
A web-based clinical trial management system for a sham-controlled multicenter clinical trial in depression. Clin Trials. 2010 Apr; 7(2):174-82.
Score: 0.013
-
Re-formulating non-inferiority trials as superiority trials: The case of binary outcomes. Biom J. 2009 Feb; 51(1):185-92.
Score: 0.013
-
Analysis of clustered matched-pair data. Stat Med. 2003 Aug 15; 22(15):2417-28.
Score: 0.009
-
Analysis of clustered matched-pair data for a non-inferiority study design. Stat Med. 2003 Jan 30; 22(2):279-90.
Score: 0.008
-
Identifying Patients at Risk for Fibrosis in a Primary Care NAFLD Cohort. J Clin Gastroenterol. 2023 Jan 01; 57(1):89-96.
Score: 0.008
-
Design and execution of sham-controlled endoscopic trials in acute pancreatitis: Lessons learned from the SHARP trial. Pancreatology. 2023 Mar; 23(2):187-191.
Score: 0.008
-
Use of the Molecular Adsorbent Recirculating System in Acute Liver Failure: Results of a Multicenter Propensity Score-Matched Study. Crit Care Med. 2022 02 01; 50(2):286-295.
Score: 0.008
-
Convalescent Plasma for Outpatients with Covid-19. Reply. N Engl J Med. 2021 12 02; 385(23):2206-2207.
Score: 0.008
-
Early Convalescent Plasma for High-Risk Outpatients with Covid-19. N Engl J Med. 2021 11 18; 385(21):1951-1960.
Score: 0.007
-
Coagulopathy, Bleeding Events, and Outcome According to Rotational Thromboelastometry in Patients With Acute Liver Injury/Failure. Hepatology. 2021 08; 74(2):937-949.
Score: 0.007
-
Advanced liver fibrosis and the metabolic syndrome in a primary care setting. Diabetes Metab Res Rev. 2021 11; 37(8):e3452.
Score: 0.007
-
Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2. Stroke. 2020 08; 51(8):2282-2286.
Score: 0.007
-
Treatment of Hyperglycemia in Patients With Acute Stroke-Reply. JAMA. 2019 12 10; 322(22):2248-2249.
Score: 0.007
-
SpHincterotomy for Acute Recurrent Pancreatitis Randomized Trial: Rationale, Methodology, and Potential Implications. Pancreas. 2019 09; 48(8):1061-1067.
Score: 0.007
-
The Association of Abnormal Liver Tests with Hepatitis C Testing in Primary Care. Am J Med. 2020 02; 133(2):214-221.e1.
Score: 0.006
-
Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial. JAMA. 2019 07 23; 322(4):326-335.
Score: 0.006
-
Low Serum Hepcidin Is Associated With Reduced Short-Term Survival in Adults With Acute Liver Failure. Hepatology. 2019 05; 69(5):2136-2149.
Score: 0.006
-
Assessing the Burden of Abnormal LFTs and the Role of the Electronic Health Record: A Retrospective Study. Am J Med Sci. 2018 Jun; 355(6):537-543.
Score: 0.006
-
Duloxetine for the Treatment of Patients with Suspected Sphincter of Oddi Dysfunction: A Pilot Study. Dig Dis Sci. 2016 09; 61(9):2704-9.
Score: 0.005
-
Intramuscular midazolam versus intravenous lorazepam for the prehospital treatment of status epilepticus in the pediatric population. Epilepsia. 2015 Feb; 56(2):254-62.
Score: 0.005